Book Now

Cancer Exercise Training

This program provides personalized physical, psychological, balance, and neurocognitive training for cancer patients. Services are available before, during, and after treatment to support recovery, boost energy, and address long-term effects of cancer treatment

Benefit of cancer exercise training:
  • Improve physical functioning and quality of life. 
  • Maintain or restore independence. 
  • Reduce risk of recurrence or secondary cancers.
  • Manage side effects (lymphedema, obesity and osteoporosis)
  • Facilitate return to normal life. 
  • Optimize treatment outcomes. 

How we work:
 All patients/clients must receive medical clearance from their oncologist or primary care provider before undergoing any assessment or beginning an exercise program. All exercise prescriptions are carefully documented, and clients will be reassessed every 12 weeks to track progress toward their goal.
Service type:
  • One-on-one training sessions
  • Small group classes
  • Online coaching and support
  • In Home training

Systemic benefit of exercise for cancer patients
Cardiovascular: Increases cardiac output & stroke volume, lower exercise heart rate, improve aerobic capacity & nutrient delivery, strengthens myocardium, decrease resting heart rate. 
Pulmonary: Strengthens intercostal muscle, improve ventilation of air in and out of the body. 
Musculoskeletal: Prevent muscle wasting (cancer-cachexia), increase muscle tissue integrity and range of motion, increase protein syntheses, improves metabolism which in turn increase the efficiency of energy utilization, Stimulate hormone release for muscle cell growth. 
Immune: Increase red blood cell production, increase blood volume 
Neural: Enhance motor unit recruitment, Improve memory, coordination, reaction, depth perception, visual acuity, neurochemical availability at the cellular & tissue level, peripheral neuropathy and increase motor neurons. 
Gastrointestinal: Increase water & nutrient uptake, improve appetite, weakness and fatigue. 
Endocrine: Increased glucose uptake: insulin dependent or independent, regulate hormone production and release, improve quality of life.

WHY ULTRA SV NEUROCOGNITION ASSESSMENT / TRAINING?

Cancer-related cognitive impairment is a side effect of cancer or its treatment that causes a decline in quality of life in cancer patients (QOL). Cancer research study treatment (chemotherapy, radiation, surgery, and targeted biological therapy) has significantly increased survival rates (Janelsins et al., 2014); however, this treatment has been linked to cognitive impairment months or years after treatment. As of January 1, 2019, there are over 16.9 million cancer survivors in the United States (ACS, 2022); 75% experience cancer-related cognitive impairment (CRCI) during treatment and 35% a month or years after treatment (Janelsins et al., 2014). This statistic is significant in demonstrating the importance of quantity over quality of life after treatment. Decades of investment in cancer research and treatment have resulted in a significant increase in survival rate when compared to when cancer was a death sentence. Several research studies of cancer patients or those who have received cancer treatment have revealed a decline in quality of life associated with cognitive impairment (memory, reaction, concentration, processing speed, executive function) (Ahles et al., 2007; Loh et al., 2016; Janelsins et al., 2014).

Subjective cognitive assessment, also known as Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), is a tool designed to assess CRCI in patients following cancer diagnosis and treatment. Using the FACT-Cog report, this assessment subjectively evaluates patient memory, concentration, multitasking ability, mental acuity, verbal fluency, and functional interferences (Vega et al., 2017). The FACT-Cog questionnaire evaluates reports of significant cognitive changes based on perceived impairment and abilities, noticeability by others, and impact on QOL (Costa et al., 2018). The reliability and construct validity of this FACT-Cog assessment remain unknown because cancer or its treatment affect patients memory, concentration, processing, and reaction speed differently (Vega et al., 2017), and prior knowledge or expectation can exacerbate the FACT-Cog report, i.e., prior knowledge of chemo brain conception (Costa et al., 2018).

Our Neurocognition assessment method offers a specialized approach, assessing memory, processing speed, concentration, and reaction speed. This comprehensive assessment occur initially and Initial is followed by reassessment every 12 weeks, spanning 27-36 sessions. These assessments guide our tailored interventions pension strategies, providing a unique support for patient dealing with Cancer Related Cognitive Impairment (CRCI) or Cancer Treatment Related Cognitive impairment (CTCI).

Assessment variable includes: reaction time (milliseconds), total memory time (seconds), latency time per correct percentage (milliseconds/correct%), left/right latency time, and left/right motor time (milliseconds); total number of targets repeated, extending the average latency time per degree of vision (milliseconds per degree),  and central and peripheral target latency times (milliseconds).